Gender & Health

Published by
CorpWatch Blog
|
By |
Should a private company be allowed to patent isolated human genes? A lawsuit to be heard Friday pits Myriad Genetics of Utah against the American Civil Liberties Union (ACLU). Myriad wants to be the exclusive U.S. commercial provider of genetic screening tests for breast cancer or ovarian cancer. Read More
Published by
CorpWatch Blog
|
By |
KLM, the Dutch airline, has been forced to backtrack from a plan to use oil from jatropha seeds grown in Indonesia for commercial flights, after Friends of the Earth Netherlands put out a report criticizing the potential impact on local food supplies. Read More
Published by
CorpWatch Blog
|
By |
Should lobbyists for biotech and food companies make the rules on what kind of food you have in your kitchen? Meet Mella Frewen, Suzy Renckens and Harry Kuiper: Three examples of how the industries take advantage of the European Food Safety Agency(EFSA) failure to properly regulate conflicts of interest. Read More
Published by
CorpWatch Blog
|
By |
Johnson & Johnson has been fined $1.2 billion in Arkansas over the sales of Risperdal, an antipsychotic drug. A circuit judge ruled that the company did not warn patients that the drug places elderly patients with dementia at an increased risk of major weight gain, possible diabetes and potential death. Read More
Published by
New York Times
|
By |
A Swiss drug company, Novartis, will go before the Indian Supreme Court this monnth to fight patent laws that protect the global supply of inexpensive medicines to treat AIDS, cancer and other diseases. The lawsuit - which involves a drug called Gleevec - is being opposed by international aid groups. Read More
* indicates required